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Introduction
Ventricular fibrillation (VF) is a result of  high frequency 
(dominant frequency  from 4.0-5.5 Hz, cycle length < 250 ms), 
irregular, interacting, re-entrant propagation of electrical excitation 
waves within the ventricular myocardium. This leads to cardiac arrest 
and death if not treated urgently with defibrillation. The electrical 
activity of VF may self-terminate [1] or be terminated by a  short, 
large amplitude (5-40 J) electrical shock delivered by an implanted 
cardioverter defibrillator (ICD) or 120-360 J applied externally. 
Defibrillation needs to be prompt: in animal studies  the threshold 
for defibrillation increases, and the probability of a successful 
defibrillation  decreases as VF persists [2].  Clinically, between  the 
first 5 and 15 seconds of VF  the probablility that a defibrillation 
shock is successful halves [3]. Defibrillation shocks can produce cell 
and tissue damage [4]. They are painful, and some patients find  the 
subjective effects of an ICD intolerable. Repeated  defibrillation 
shocks, even when appropriate  and successful,  are associated with 
increased morbidity and mortality [5]. Although life style changes 
and pharmacological agents can reduce the risk of VF, electrical 
defibrillation is the most effective means of treating VF [6]. There is 
therefore great interest clinically in the concept of achieving painless 
defibrillation by using a repetitive sequence of high frequency, low 
energy, antifibrillation pacing stimuli,  rather than a single large 
defibrillation shock. Defibrillation by high frequency pacing has been 
achieved in isolated perfusd atrial [7] and ventricular [8] preparations. 
Clinically, anti-tachycardia pacing  (ATP) is a short sequence of  high 
frequency pacing stimuli, where the pacing interval may be constant 
(typically 88% of the tachycardia cycle length), or determined by a 
decreasing fraction of  the preceeding cycle length [9].  Implantable 
cardioverter defibrillators may be routinely programmed to deliver a 
sequence of ATP once a tachycardia is detected.  Atrial ATP is not 
effective in terminating persistent episodes of atrial fibrillation [10], 
but  can terminate the  slower atrial flutter or tachycardia [11]. This 
has been exploited in reactive ATP, where ATP is applied whenever 
atrial fibrillation spontaneously transitions to  flutter or tachycardia 
[12]. Terminating these more organised episodes slows the disease 
progression and leads to a reduced atrial fibrillation burden [13].
ATP  is well established for the control of “slow” ventricular 
tachycardia, with  cycle length more than 250 ms [14]. A defibrillation 
shock may then be applied if the ATP sequence had failed. A role for 
ATP in VF , however, has not been established.
Downloads from implantable cardiac devices,  and intra cardiac 
recordings during clinical electrophysiological testing in humans, can 
provide time series data for characterising idiopathic and induced 
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Abstract
Cardioversion and defibrillation by a single high energy shock applied by myocardial or body surface electrodes is painful,  causes long 
term tissue damage, and is associated with  worsening long term outcomes, but is almost always required for treatment of ventricular 
fibrillation .
As a initial step towards developing methods that can terminate ventricular arrhythmias painlessly, we aim to determine if  pacing stimuli 
at a rate of 5/s  applied via  an implantable cardiac defibrillator (ICD) can modify human ventricular fibrillation.
In 8 patients undergoing defibrillation testing of a new/exchanged intracardiac defibrillator,  five seconds of  pacing at five stimuli per 
second was applied during the 10-20 seconds of  induced ventricular fibrillation before the defibrillation shock was automatically applied, 
and the cardiac electrograms recorded and analyzed.
The high frequency pacing did not entrain the ventricular fibrillation, but altered the dominant frequency in all 8 patients,  and modulated 
the phase computed via the Hilbert Transform, in four of the  patients.
In this pilot study we  demonstrate that high frequency pacing applied via ICD electrodes during VF can alter the dominant frequency and 
modulate the probability density of the phase  of the electrogram of the ventricular fibrillation.
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Helsinki. Written informed consent was obtained from each patient.
Consecutive patients undergoing de novo implant, revision, or 
generator change of trans-venous implantable cardiac defibrillator 
(ICD) or cardiac resynchronisation defibrillator (CRT-D) devices at 
the West Yorkshire Arrhythmia Service, Leeds General Infirmary, 
and who were to undergo planned defibrillation testing as part of 
their routine medical care, were included in this study [Table 1]. 
The ICD or CRT-D device and trans-venous leads were implanted 
according to standard of care. The device pocket was prepared at the 
left pectoral region.  After the pocket was closed, VF was induced 
from the implanted device using either 2 s of pacing at a rate of 
50/s   by 8.0 V and 1.5 ms rectangular pulses,  or a by delivery of a 5J 
shock on the T wave. Prior to 50/s pacing VF inductions, the ICD 
capacitors were charged to intended defibrillation energy to reduce 
time to the  defibrillation shock. VF was induced only once in any 
one patient.
All patients were implanted with ICD or CRT-D. A programmer 
was used for programming and interrogation of the implanted device 
and to induce VF using the electrophysiological testing capabilities 
VT and VF in humans [15].  During clinical defibrillator testing in the 
cardiac catheterization laboratory, the 10-30 s of induced VF provides 
a narrow window for examining any effects of applied perturbations 
on the  recorded VF. 
In this  percutaneous human pilot study using standard  clinical 
intracardiac defibrillation hardware,  within the confines of a hospital 
cardiac electrophysiology catheter intervention  laboratory,  the 
objective was to determine whether the delivery of high frequency 
pacing at 5/s via intra-myocardial defibrillator leads during VF can 
alter the quantitative characteristics of the cardiac electrograms 
(EGMs) during VF.
Methods
This study was registered on ClinicalTrials.gov on 14th 
December 2015 with the ClinicalTrials.gov registration number: 
NCT02629445, and received ethics approval from the North West 
- Greater Manchester West Research Ethics Committee (15/
NW/0722). The study protocol  was carried out in accordance with the 
relevant guideslines and regulations of the Leeds General Infirmary, 
and conforms to the ethical guidelines of the 1975 Declaration of 
Table 1: Patient Characteristics.
Patient Number Age Gender LV Function Ischaemia Device Type DFT Performed Induction Type CS Lead Configuration
1 67 Male Severe Y ICD N na na
2 80 Male Severe Y CRT-D N na LV2-LV3
3 51 Male Severe N ICD Y 50/s na
4 73 Male Severe Y CRT-D Y 50/s LV1 - Coil
5 54 Female Moderate N CRT-D Y T wave shock LV tip - RVC
6 74 Male Severe Y CRT-D Y 50/s LV3-LV4
7 83 Male Severe Y CRT-D Y T wave shock Unknown
8 69 Male Severe N CRT-D N 50/s Bipolar
9 73 Male Moderate N CRT-D Y 50/s LV3-LV4
10 47 Male Severe N ICD N T wave shock na
11 57 Female Normal N ICD Y 50/s na
12 30 Male Severe N ICD Y 50/s na
13 29 Female Severe N ICD N na na
The study protocol could not be carried out in patients highlighted in gray. Fibrillation was induced either by 2 s of pacing at a rate of 50/s   by 8.0 V and 1.5 ms rectangular pulses,  or a by delivery of a 
5 J shock on the T wave.
Table 2: Quantitative characteristics of ventricular fibrillation during testing.
Patient Phase modulation pre-pacing Phase modulation during pacing Phase modulation post-pacing DF pre-pace DF during pace DF post-pace
3 0.0241 ± 0.0120 0.0135 ± 0.0103 0.0156 ± 0.0035 5.10 ± 0.14 5.39 ± 0.21 5.28 ± 0.28
4 0.0066 ± 0.0075 0.0082 ± 0.0026 0.0053 ± 0.0030 3.71 4.11 4.09
5 0.0354 ± 0.0208 0.0405 ± 0.0378 0.0474 ± 0.0383 4.35 ± 0.98 4.42 ± 0.21 4.43 ± 0.03
6 0.0148 ± 0.0080 0.0191 ± 0.1175 0.0079 ± 0.0029 5.13 ± 0.58 5.37 ± 0.06 5.50 ± 0.13
8 0.0148 ± 0.0135 0.0133 ± 0.0079 0.0082 ± 0.0020 4.66 ± 0.17 4.91 ± 0.16 4.87 ± 0.46
9 0.0222 ± 0.0179 0.0081 ± 0.0043 0.0087 ± 0.0054 4.87 5.12 4.73 ± 0.20
10 0.0308 ± 0.0221 0.0381 ± 0.0279 0.0200 ± 0.0106 4.95 ± 0.13 5.0 5.80 ± 0.35
12 0.0113 ± 0.0091 0.0631 ± 0.0216 0.0086 ± 0.0063 4.16 4.94 ± 0.04 4.59 ± 0.06
All 0.0200 ± 0.0156 0.0255 ± 0.0249 0.0152 ± 0.0178 4.62 ± 0.49 4.91 ± 0.43 4.91 ± 0.58
Phase modulation = modulation amplitude of probability densities (as in figure 4). DF = Dominant Frequency (Hz)
Data are mean ± standard deviation across all EGM/pseudoECG channels. Where no standard deviation is presented, the same DF value across all channels was obtained.
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of the implanted defibrillator. A breakout box was connected to 
the programmer and provided access to analogue signals that were 
continuously telemetered from the device. The breakout box provided 
analogue signals for the device marker information, the far field ECG 
was derived from the implant, and two EGM channels were derived 
from the right and/or left ventricular lead system. The EGM source 
and source sensitivity were selected on the programmer, depending 
on the lead system and EGM signal amplitude. Analog signals were 
digitized at 22 bit amplitude resolution and 500 samples/s using 
standard data recording equipment. 
Once VF was induced, repetitive 5/s pacing was delivered from 
the RV tip or an LV electrode for approximately 4-5 s at a cycle 
length of 200 ms, at maximum output of 1.5 ms pulse width and 8.0 
V. The pacing frequency was selected as it was within the range of 
dominant frequencies characteristic of human ventricular fibrillation 
and faster than the frequencies used in anti-tachycardia pacing [15]. 
EGMs were recorded from the RV coil and the atrial electrode for 
the right ventricle, and between the two LV electrodes adjacent to 
the LV stimulation electrodes for the left ventricle. Each patient only 
underwent one defibrillation test.
Data were converted from its proprietary poly5 (TMSI Porti) 
format and exported as .csv files, which were analysed (Short Term 
Fourier Transform, Hilbert Transform for phase) and plotted. Prior 
to analysis, the signals were low pass filtered with a 45Hz cut off 
and high pass filtered with a 1Hz cut off.  We performed a Hilbert 
transformation analysis [16]. If v(t) and p(t), both of the same duration, 
are the recorded EGM and a 5Hz cosine phase locked to the repetitive 
pacing signal, and       and       are their Hilbert transforms, the phase 
was calculated from equation 1: 
                                                                                                  (1)
Dominant frequency and phase values were calculated during VF 
before, during and after the pacing intervention. The differences in 
dominant frequency and phase were quantified.
The phase, computed using the Hilbert transform from equation 1 
as demonstrated in [Figure 2D], is bounded and distributed between, 
-90° and +90°. If there is no relation between the EGM and the 
reference signal, the phase will be uniformly distributed, with the 
probability density histogram fluctuating randomly about a constant 
value of 1/180°. Modulation of the probability density histogram is 
used as an indicator of a phase entrainment  by the high frequency 
Figure 1:
Sample raw recordings from CRTD/ICD.  During a defibrillation test ventricular fibrillation is induced by (A) manually controlled 50/s 
repetitive stimulation, and, if this fails on the second attempt, by (B) 9 stimuli ( 8.4 V, 1.5 ms, cycle length 410 ms)  followed by a 5 J   
shock  after 400 ms. The 5/s pacing burst is switched on manually after VF has been established for about 5 s. The red lines in A and 
B mark the defibrillation shock controlled by the ICD algorithm, the green line  in B the shock on the T-wave, controlled by the device. 
(a) is the marker channel (upward stroke atrial signal, downward stroke ventricular signal), (b) the far field EGM -  pseudo ECG, (c) 
EGM1 and (d) EGM2. A is from patient 8, B from patient 5.
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pacing intervention of the EGM during ventricular fibrillation. The 
modulation of the probability density histogram was quantified using 
the amplitude of a single cycle of a cosine fitted to the histogram.
 
Data is represented as mean ± standard deviation unless otherwise 
stated.
All data generated or analysed during this study are included in 
this published article (and its Supplementary Information files).
Thirteen patients were enrolled. Eight patients underwent the 
pacing protocol with defibrillation testing . Defibrillation testing 
could not be performed for clinical reasons in the five excluded 
patients. The baseline characteristics of the patients studied and the 
devices which were implanted are shown in [Table 1].
50/s stimulation induced sustained VF in 6 of the 8 patients. In 
the remaining 2 patients, sustained VF was initiated by a low energy 
shock synchronised to the T wave. The interval between initiation 
of VF until defibrillation shock delivery from the implanted device 
was < 20.4 s (18.03 ±2.3s ) , giving  6.79±1.03 s of VF before pacing, 
4.87±0.834  s of VF during 5 /s pacing and 6.38±2.13 s of VF after 
pacing (see Supplementary data).
The magnitude of the EGMs during ventricular fibrillation, either 
as the peak-peak amplitude of the three EGM signals, as in [Figure 
1B,C,D] and [Figure 2B], or as the root-mean-square amplitude/
Hz of their frequency spectra, did not change during high rate 
high output ventricular pacing intervention . A clear reduction in 
amplitude was only observed in one patient (see Supplementary 
Figures). 
Figure 2:
Characterization of ECG surrogate during ventricular fibrillation induced by 50/s pacing: (a) marker channel;  (b) the  far field EGM -  
pseudo ECG (low-pass filtered to 45 Hz, zero-meaned and normalised); (c) Chrono-spectrum of pseudo ECG, the normalized root mean 
square amplitude of the spectrum is colour coded with a linearly mapped colour look-up table. (d) Phase angle of ECG surrogate, 
estimated by equation (1). The red box outlines the period of pacing at 5/s  Data from patient 12.
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propagating wave, or a boundary of the tissue. These irregular, 
moving, writhing narrow sheets form the recovered  excitable tissue 
that can be influenced by electrical stimuli or shocks.  The electrical 
stimulation  alters  the spatio-temporal pattern of propagation, by 
altering the cell membrane potentials, tissue excitability , or exciting 
new action potentials, If the excited cells form a compact, sufficiently 
large volume of tissue, activity can propagate and capture surrounding 
myocardium. 
The theory of nonlinear waves in excitable media provides  an 
understanding of the spatio-temporal structures and dynamics of the 
electrical activity driving VF, and how they are modified by anisotropic 
propagation and heterogeneities [19]. Optical mapping in vitro 
experiments can give a two dimensional, surface view  of re-entrant 
arrhythmia, and  when combined with simultaneous high resolution 
ultrasound imaging the  associated three dimensional  scroll wave 
mechanical filament has been recorded in animal hearts [20]. Bidomain 
theory [21] provides an approach to how stimulation from electrodes in 
or near the heart can excite and pace the myocardium, or defibrillate 
via the induction of virtual electrodes [22]. These theories have been 
used to design [23] and test  methods to produce defibrillation by 
repetitive trains of small amplitude electrical stimuli, numerically [24, 
25] , in vitro, on cell cultured preparations and isolated perfused hearts, 
and in acute animal preparations [8, 26 -27]. 
The physical rationale for defibrillation by low amplitude repetitive 
pacing is that if VF  is driven by  interacting, multiple re-entrant 
waves, then progressive elimination of these re-entrant waves or 
rotors will terminate fibrillation [21,25]. If an isolated rotor is idealized 
as a pinned or a meandering  free stable spiral or scroll wave in a 
two and three-dimensional excitable medium [28], then repetitive 
perturbations can unpin it and also produce a drift in the position 
of the core, or filament, of the wave. Repetitive, appropriately timed 
stimulation would act to  gently push the core out of the medium [23]. 
The amplitude Fourier spectra of the EGMs during the VF before, 
during and after pacing have the harmonic structure characteristic of 
a repetitive waveform, with a single, large, dominant frequency (DF) 
component and smaller peaks at integer multiples of this DF [Figure 
3A].  In all eight patients the high frequency pacing increased the 
DF of the ventricular fibrillation EGM, from  from 4.6 ± 0.47 to 
4.9  ±  0.41  -  see data in [Table 2]. The increase of the dominant 
frequency was maintained throughout the rest of the episode until 
the VF was defibrillated [Figure 3B]. The DF change from 4.6 ± 0.48 
to 4.9 ± 0.58 Hz   from the pre- to post-pacing intervals.
Estimated probability density histograms are illustrated in [Figure 
4A-4D]. During pacing [Figure 4C]  there is clear modulation of the 
probability density. [Figure 4E] shows an increase in the  amplitude 
of the modulation of the probability density histogram in 4 of the 8 
patients.
The quantitative characteristics of the dominant frequency and 
phase are presented in [Table 2].
Discussion
VF is sustained by irregular, multiple  re-entrant wave trains that 
are propagating  in the excitable myocardial tissue, with a velocity 
of 0.2-0.7 m/s  and have a rate of ~5/s [17]. During clinical VF there 
can be about 10 re-entrant sources [18] that generate  propagating 
wavefronts The waves are composed of irregular action potentials, 
that spread into tissue that has recovered its excitability, by local 
circuit currents. 
The tissue into which the depolarising wavefronts  of the action 
potential propagate at any instant in time will be smoothly crumpled, 
curved sheets, of variable width, each  ahead of a propagating 
wavefront, and behind the repolarisation waveback of the  preceeding 
Figure 3:
Dominant frequencies of cardiac electrograms during induced ventricular fibrillation: (a) normalised rms amplitude spectra of initial 
VF (black) that is followed by  5 s of  5 /s pacing (red) then  VF  (blue) before automated defibrillation. Patient 12. Frequency scale 
expanded in inset. (b) dominant frequencies of VF electrogram before (pre), during (pace) and after (post) pacing at 5 /s. Numbers 
adjacent to each plot correspond to patient number as in table 1.
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A few bursts of far field repetitive stimulation of ~10% defibrillation 
single shock amplitude have been shown to be able to terminate re-
entry in an isolated  canine heart [26].
Although the possible  mathematical, physical and biophysical 
mechanisms of defibrillation can be dissected in isolation in animal 
and tissue model systems, and the isolated perfused human heart 
[29]  mechanisms for clinical defibrillation need to be studied and 
tested in human hearts, as the quantitative  details of propagation 
phenomena are species specific, and in vivo, as cardiac excitability and 
propagation are influenced by sympathetic activity . 
In this first in human study, we have demonstrated that 5/s 
high frequency high output pacing intervention applied via ICD 
electrodes during VF can alter the  quantitative characteristics of  the 
VF electrograms. These changes with  time, of  frequency, phase and 
amplitudes imply that the spatio-temporal pattern of activity, or the 
propagating activity, that produces ventricular fibrillation  have been 
modified by the pacing stimuli.  In these experiments the VF before 
and after the pacing act as the controls, and the VF during the pacing 
as the test. 
There is an apparent increase in the DF from before pacing to during 
pacing ([Figure 3B, [Table 2]). This higher DF can be  maintained 
post pacing.  However, the increase in DF  may not be produced 
by the pacing itself, but result from the evolution of  the properties 
of VF with time since its initiation, as seen in unpertubed, induced 
VF [17]. Since the duration of the pre-, during and post-pacing VF 
recordings are short, the spectral estimates have a low resolution and 
consistency (few degrees of freedom). However, the values in [Figure 
3B] are consistent with:
• the range of DF in optical recordings of evoked VFevoked 
episodes in isolated perfused human hearts , from 5.4 to 6.8 Hz [29], 
• the increase in the global  mean DF of the cardiac electrograms 
reported between 1 and 30 s during induced episodes of VF in vivo, 
from 3.9 ± 0.8  to 5.9± 1.0 Hz  [30] 
• and the increase in DF, at a rate of rate of 0.018 ± 0.005 Hz/ 
s during VF induced by burst pacing reported during open chest 
surgery using a 256 electrode epicardial sock  [30].
The modulation of the estimated probability density histograms 
([Figure 4], [Table 2])  for the phase is only observed during the 5 
/s pacing, and is a reversible effect of the 5 /s pacing.  Modulation 
is observed in the far field ECG channel, and both recorded EGM 
channels of [Figure 1], in 4 of the 8 patients.The EGMs for each 
of these channels is the potential between two adjacent electrodes 
on the ICD leads. In a mono-domain and bi-domain models of the 
heart this would be modelled by a weighted integral of the spatio-
temporal activity. Any change in the EGMs produced by the pacing 
could be produced by changes in both, or either of, the temporal and 
spatial activity during VF.
The 3D spatio-temporal pattern of activity during clinical VF has 
not been observed. In isolated, perfused hearts, the epicardial surface 
pattern of excitation during VF (with phase singularities identified 
as the intersection of a reentrant vortex filament with the surface) 
are consistent with VF resulting from multiple reentrant vortices [17 
-19]. The re-entrant waves propagate into tissue that has recovered its 
excitability. Numerical modelling of the evolution of VF following 
initiation of a single scroll wave by an S1S2 protocol shows that 
during the first 30 s of induced VF there are multiple, irregular re-
entrant waves with fluctuations in the number of vortex filaments, 
Figure 4:
Estimated probability density histograms for phase relative to 5Hz cosine, calculated by equation (1), during induced fibrillation (a) 
during 50/s pacing induction (b) before 5/s pacing (c) during 5/s pacing and (d) after 5/s pacing and before defibrillation shock.  
The red dashed line is the density predicted on the assumption that there is no relation between the cardiac electrogram during 
fibrillation and the 5/s pacing signal (it is 1/18 as the bins  are 10° wide). Patient 12 channel b. (e) Modulation amplitude of the 
probability densities (pre) before pacing, (pace) during 5/s pacing and (post) after 5/s pacing and before defibrillation shock. 
Numbers adjacent to each plot correspond to patient number as in table 1.
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Supplementary Materialswhich range between 5-20 (mean~11)  [31]. During VF there are thin, 
moving, sheet-like volumes of tissue that have recovered excitability, 
and are ahead of and about to be invaded by the propagating wave-
front surfaces. Parts of this spatio-temporal excitable gap that are 
close to the active electrodes may be excited by the pacing stimuli, 
either sub-threshold, or initiating action potentials that propagate 
and capture a surrounding volume. A changed distribution of 
excitability in the excitable gap and/or partial capture would account 
for the modulation of phase probability density and increase in DF 
shown in [Figure 3-4].
The high frequency pacing burst did not terminate the VF in any 
of the subjects, but phase entrainment of the cardiac electrograms 
was produced.  The phase entrainment reflects a decrease in the 
complexity, or increase in the orderliness of the  VF, simplifying VF to 
a process closer to a high frequency VT. The ability of high frequency 
periodic stimuli to modify the spatio-temporal patterns of  the 
electrical activity that produces VF raises the possibility of modifying 
VF to a VT  that can then be terminated by an appropriately timed, 
repetitive sequences of pulses.
Study Limitations
The number of leads for pacing and sensing, and their positioning, 
is determined by the implanted device, and is not designed to be 
optimal for capturing myocardium. Multiple or long line elctrodes 
that provide wide area, surface stimulation of the ventricule would 
be more effective [32]. In order to minimise the duration of VF, and 
therefore risk to the patient, stimulation was not prolonged beyond 
five seconds, and there was only one test per patient, to allow the 
defibrillation shock to be applied within 10 seconds. The effects of 
repeated and prolonged stimulation could  be investigated in animal 
or in vitro experiments. 
The principal limitation of this proof of concept study  is the small 
number of participants, hence the paucity  of statistical analysis. 
Defibrillation testing is now no longer routinely undertaken, and 
therefore it would be difficult to increase patient numbers.
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Conclusion
In this first in human study, we have demonstrated that a high 
frequency (5/s)  high pacing intervention can modify VF, presumably 
by exciting or possibly by capturing parts of the myocardium in 
the excitable gap of VF. Harnessing this has potentially useful 
implications in extending the delivery of painless pacing from 
slow and fast VT  to VF. Such development could be approached 
by  incorporating data acquired during invasive clinical ventricular 
electrophysiological investigation and mapping  (illustrative examples) 
with  computational simulations (repeated experiments within the 
same ventricular geometry, or over populations of geometries) [33].














3 4.238 4.054 5.45 6.62 20.362
4 2.742 3.588 3.646 8.872 18.848
5 N/A 6.804 4.722 7.346 18.872 Shock on T
6 3.132 3.274 4.642 5.152 16.2
8 2.652 3.778 4.432 2.48 13.342
9 3.352 3.288 6.434 5.06 18.134 First 2 VF 
inductions self-
terminated
10 N/A 8.196 5.238 6.674 20.108 Shock on T
12 3.216 1.916 4.44 8.826 18.398
Patients 5 and 10 : two episodes of 50/s stimulation failed to induce VF, and the data is from the 
shock on T initiation that precedes the defibrillation. For patient 10, the 8.2 s of VF preceding the 
test 5/s pacing includes a short period of pacing.
The data sets, from the last cycles of normal sinus rhythm, through VF induction and pacing, to the 
defibrillation shock, are illustrated in the following figures. A,B,C and D are the channels of a,b,c 
and d of Figure 1.
These data are attached in a .csv file as Holdenetal Supplementary Data.csv in the format:
Link for Patient_ID.csv File:
http://jafib.com/PMC/XML/Inprogress/2217/Patient_ID.csv
Figure S1: Supplementary Figure 1
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Figure S2: Supplementary Figure 2
Figure S3: Supplementary Figure 3
Figure S4: Supplementary Figure 4
Figure S5: Supplementary Figure 5
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Figure S6: Supplementary Figure 6
Figure S7: Supplementary Figure 7
Figure S8: Supplementary Figure 8
References
1. Krummen DE, Hayase J, Morris DJ, Ho J, Smetak MR, Clopton P, Rappel WJ, 
Narayan SM. Rotor stability separates sustained ventricular fibrillation from self-
terminating episodes in humans. JACC  104;  24: 2712-21.
2.  Jin Q, Zhou J, Zhang N, Lin C, Pang Y, Xin Y, Pan J, Shen W, Wu L. Defibrillation 
threshold varies during different stages of ventricular fibrillation in canine hearts 
Heart Lung Circ 2013; 22:133-40.
3. Winkle RA. Effect of duration of ventricular fibrillation on defibrillation efficacy 
in humans  Circulation  1990; 81: 1477-81. 
4. Wang YT, Efimov IR, Cheng Y. Electroporation induced by internal defibrillation 
shock with and without recovery in intact rabbit hearts. Am J Physiol Heart Circ 
Physiol 2012;  303:  H439-49.
5. Walcott GP, Killingsworth CR, Ideker RE. Do clinically relevant transthoracic 
defibrillation energies cause myocardial damage and dysfunction? Resuscitation 
2001;59:59-70.
6. Dresen WF, Ferguson JD. Ventricular Arrhythmias Cardiol Clin 2018 36 129-
139. 
7. Fenton FH, Luther S, Cherry EM, Otani NF, Krinsky V, Pumir A, Bodenschatz 
E, Gilmour RF Jr. Termination of atrial fibrillation using pulsed low-energy far-
field stimulation. Circulation. 2009;120:467–476.
8. Luther S, Fenton FH, Kornreich BG, Squires A, Bittihn P, Hornung D, Zabel M, 
Flanders J, Gladuli A, Campoy L, Cherry EM, Luther G, Hasenfuss G, Krinsky 
VI, Pumir A, Gilmour RF Jr, Bodenschatz E. Low energy control of electrical 
turbulence in the heart. Nature. 2011;475:235– 239. 
9. Duncker D, Veltmann C. Optimizing Antitachycardia Pacing: Back to the Roots. 
Circ Arrhythm Electrophysiol. 2017 Sep;10(9). 
10. Mitchell AR1, Spurrell PA, Cheatle L, Sulke N. Effect of atrial antitachycardia 
www.jafib.com Dec 2019 - Jan 2020| Volume 12| Issue 4 
Featured ReviewJournal of Atrial FibrillationJ r l f tri l i rill ti10 Original Research
Mironov S, Sevaptsidis E, Rogers J, Wright G , and Dhopeshwarkar R.   Optical 
mapping of Langendorff-perfused human hearts: establishing a model for the 
study of ventricular fibrillation in humans. Am J Physiol Heart Circ Physiol 2007; 
293: H875-880.
30. Nash MP, Mourad A, Clayton RH, Sutton, PM, Bradley CO, Haywayd M, 
Paterson DJ, Taggart P. Evidence for multiple mechanisms in human ventricular 
fibrillation Circulation  2006;114:536-542. 
31. Kazbanov IV, Clayton RH, Nash MP, Bradley CP, Paterson DJ, Hayward MP, 
Taggart P, Panfilov AV. Effect of global cardiac ischemia on human ventricular 
fibrillation: insights from a multi-scale mechanistic model of the human heart 
PLoS Comput  Biol  2014;10: e1003891.
32. Moreno A, Walton RD1, Constantin M, Bernus O, Vigmond EJ, Bayer JD. 
Wide-area low-energy surface stimulation of large mammalian ventricular tissue. 
Sci Rep. 2019 Nov 1;9(1):15863. 
33. Niederer DA, Lumens J, Trayanova NA. Computational models in cardiology. Nat 
Rev Cardiol 2018; 16: 100-111.
pacing treatments in patients with an atrial defibrillator: randomised study 
comparing subthreshold and nominal pacing outputs. Heart. 2002 May;87(5):433-
7. 
11. Peters, R. W., Shorofsky, S. R., Pelini, M., Olsovsky, M. & Gold, M. R. Overdrive 
atrial pacing for reversion of atrial flutter: comparison of postoperative with 
nonpostoperative patients. Am. Heart J. 137, 100–103 (1999).
12. Boriani G, Tukkie R, Manolis AS, et al. Atrial antitachycardia pacing and 
managed ventricular pacing in bradycardia patients with paroxysmal or persistent 
atrial tachyarrhythmias: The MINERVA randomized multicentre international 
trial. Eur Heart J. 2014;35:2352‐236
13. Crossley GH, Padeletti L, Zweibel S, Hudnall JH, Zhang Y, Boriani G. Reactive 
atrial-based antitachycardia pacing therapy reduces atrial tachyarrhythmias. 
Pacing Clin Electrophysiol. 2019 Jul;42(7):970-979. doi: 10.1111/pace.13696. 
Epub 2019 Apr 29.
14. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, 
Canby RC, Khalight K, Machado C, Tubenstein DS, Volosin KJ, PainFREE 
Rx II Investigators. Prospective randomized multicenter trial of empirical 
antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia 
in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular 
Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results Circulation 
2004; 110: 2591-2596.
15. Panfilov, I, Lever, NA, Smaill, BH, Larsen, PD. Ventricular fibrillation frequency 
from implanted cardioverter defibrillator devices Europace 2009;11: 1052–1056. 
16. Rosenblum M, Pikovsky A, Jürgen Kurths J, Schäfer C, Tass PA , Phase 
synchronization:from theory to data analysis In: Handbook of Biological Physics, 
Elsevier Science, Series Editor AJ Hoff, Vol 4, Neuro-informatics, Editors: F 
Moss and S Gielen, 2001 Chapter 9, pp 279-321.
17. Jalife J. ,Dynamics and Molecular Mechanisms of Ventricular Fibrillation in 
Structurally Normal Hearts. Card Electrophysiol Clin 2016; 8::601-12 
18. ten Tusscher KH, Mourad A, Nash MP, Clayton RH, Bradley CP, Paterson 
DJ, Hren R, Haywood M, Panfilov AC, Taggart P. Organization of ventricular 
fibrillation in the human heart: experiments and models Exp Physiol 2009; 94: 
553-62.
19. Pandit SV, Jalife J. Rotors and the dynamics of cardiac fibrillation  Circ Res 
2013;112: 849-62.
20. Christoph J, Chebbok M, Richter C, Schröder-Schetelig J, Bittihn P, Stein S, 
Uzelac I, Fenton FH, Hasenfub G, Gilmour RF Jr, Luther S. Electromechanical 
vortex filaments during cardiac fibrillation  Nature  2018; 555: 667–672. 
21. Basser PJ, Roth BJ. New currents in electrical stimulation of excitable tissues 
Annual Rev Biomed Eng  2000; 2: 377-97.
22. Trayanova NA, Rantner LJ. New insights into defibrillation of the heart from 
realistic simulation studies Europace  2014; 16: 705-13. 
23. Biktashev VN, Holden AV. Design principles of a low voltage cardiac defibrillator 
based on the effect of feedback resonant drift J Theor Biol  1994; 169: 101-112.
24. Morgan SW, Plank G, Biktasheva IV, Biktashev VN. Low energy defibrillation in 
human cardiac tissue: a simulation study Biophys J   2009; 96, 1364-1373. 
25. Buran P, Bär M, Alonso S, Niedermayer T. Control of electrical turbulence by 
periodic excitation of cardiac tissue Chaos 2017; 27: 113110.
26. Ji YC, Uzelac I, Otani N, Luther S, Gilmour RF Jr, Cherry EM, Fenton FH 
Synchronization as a mechanism for low-energy anti-fibrillation pacing Heart 
Rhythm 2017; 14: 1254-1262.
27. Hornung D  Biktashev VN, Otani NF, Shajahan TK, Baig, T, Berg S, HanS, 
Krinsky VI, Luther S. Mechanisms of vortices termination in the cardiac muscle 
R Soc Open Sci  2017;4: 170024.
28. Cherry EM, Fenton FH, Gilmour RF Jr. Mechanisms of ventricular arrhythmias: 
a dynamical systems-based perspective Am J Physiol Heart Circ Physiol 2012; 
302: H2451-63.
29. Nanthakumar K, Jalife J, Massé S, Downar E, Pop M,, Asta J, Ross H, Rao V, 
